Information Journal Paper
APA:
Copy. (2019). Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer. JOURNAL OF PHARMACY & BIOALLIED SCIENCES, 11(4), 0-0. SID. https://sid.ir/paper/990996/en
Vancouver:
Copy. Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer. JOURNAL OF PHARMACY & BIOALLIED SCIENCES[Internet]. 2019;11(4):0-0. Available from: https://sid.ir/paper/990996/en
IEEE:
Copy, “Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer,” JOURNAL OF PHARMACY & BIOALLIED SCIENCES, vol. 11, no. 4, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/990996/en